These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 18458565)
21. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391 [TBL] [Abstract][Full Text] [Related]
22. Clinical experience with activated factor VII: focus on safety aspects. Roberts HR Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S115-8. PubMed ID: 9819041 [TBL] [Abstract][Full Text] [Related]
23. Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation. Zhuang JL; Jiang QW; Xu Y; Wang SJ Chin Med J (Engl); 2011 Oct; 124(19):3189-91. PubMed ID: 22040579 [TBL] [Abstract][Full Text] [Related]
24. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352 [TBL] [Abstract][Full Text] [Related]
25. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Moscardó F; Pérez F; de la Rubia J; Balerdi B; Lorenzo JI; Senent ML; Aznar I; Carceller S; Sanz MA Br J Haematol; 2001 Jul; 114(1):174-6. PubMed ID: 11472364 [TBL] [Abstract][Full Text] [Related]
26. A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life. Veldman A; Josef J; Fischer D; Volk WR Pediatr Crit Care Med; 2006 Jan; 7(1):34-9. PubMed ID: 16395072 [TBL] [Abstract][Full Text] [Related]
27. Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Uhrig L; Blanot S; Baugnon T; Orliaguet G; Carli PA; Meyer PG Pediatr Crit Care Med; 2007 Nov; 8(6):576-9. PubMed ID: 18062085 [TBL] [Abstract][Full Text] [Related]
28. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice. Murkin JM Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007 [TBL] [Abstract][Full Text] [Related]
29. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Franchini M; Manzato F; Salvagno GL; Lippi G Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943 [TBL] [Abstract][Full Text] [Related]
30. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167 [TBL] [Abstract][Full Text] [Related]
31. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579 [TBL] [Abstract][Full Text] [Related]
32. Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study. Cosar H; Isik H; Cakır SC; Yar N; Goksen B; Tokbay H; Kertmen H; Erdoğan N; Durak I Paediatr Drugs; 2017 Feb; 19(1):53-58. PubMed ID: 27826851 [TBL] [Abstract][Full Text] [Related]
33. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia. Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426 [TBL] [Abstract][Full Text] [Related]
34. Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants. Vavra KA; Lutz MF; Smythe MA Ann Pharmacother; 2010 Apr; 44(4):718-26. PubMed ID: 20233918 [TBL] [Abstract][Full Text] [Related]
36. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta. Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726 [TBL] [Abstract][Full Text] [Related]
37. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII. Tawfick WA; Tawfik S; Hynes N; Mahendran B; Sultan S Vascular; 2006; 14(1):32-7. PubMed ID: 16849021 [TBL] [Abstract][Full Text] [Related]
38. Recombinant activated factor VII use in critically ill infants with active hemorrhage. Jen H; Shew S J Pediatr Surg; 2008 Dec; 43(12):2235-8. PubMed ID: 19040942 [TBL] [Abstract][Full Text] [Related]
39. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage. Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674 [TBL] [Abstract][Full Text] [Related]
40. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]